等待开盘 09-16 09:30:00 美东时间
-0.180
-4.49%
Minerva Neurosciences, Inc. announced that its management will participate in two upcoming investor conferences: the Wells Fargo Healthcare Conference on September 8 and the 2026 Cantor Global Healthcare Conference on September 9, both in New York. The events will include 1x1 meetings and a fireside chat. Interested investors can contact conference representatives or access the live webcast via the company's website. Minerva Neurosciences is focu...
08-28 12:00
今日重点评级关注:富瑞:维持ProMIS Neurosciences"买入"评级,目标价从69美元升至100美元;Benchmark:维持Cineverse"买入"评级,目标价从12美元升至14美元
08-17 13:37
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Stifel analyst Jonathan Siegmann upgraded Intuitive Machines Inc (NASDAQ:LUNR) from Hold to Buy a...
08-14 20:55
Jefferies analyst Biren Amin upgrades Minerva Neurosciences (NASDAQ:NERV) from Hold to Buy and raises the price target from $7.5 to $10.
08-14 20:41
Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 9.09 percent. This is a 76.74 percent increase over losses of $(0.43) per share from the same period last year.
08-07 19:42
Minerva Neurosciences ( ($NERV) ) has shared an announcement. On May 27, 2026, ...
05-28 05:25
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001598646/000119312526241930/d119518d8k.htm
05-28 04:51
Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.13) by 30.77 percent. This is a 66 percent increase over losses of $(0.50) per share
05-05 20:17
今日重点评级关注:Ascendiant Capital:维持Knightscope"买入"评级,目标价从25美元升至26美元;杰富瑞:维持Allogene疗法"买入"评级,目标价从6美元升至10美元
04-16 10:14